April 2025 - Page 6 of 6 - NetworkNewsWire

ThursdayApr 03, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Advances Phase 3 Replication Study for Early-Stage Cutaneous T-Cell Lymphoma Treatment

Soligenix is enrolling patients in its FLASH2 study, with a formal interim analysis anticipated early in 2026. SNGX’s HyBryte is a novel photodynamic therapy using synthetic hypericin activated by safe visible light. The ongoing phase 3 replication study meets stringent requirements of regulatory agencies to strengthen the case for HyBryte as a commercially available treatment. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in the development and commercialization of treatments for rare diseases and unmet medical needs, is making significant strides in its efforts to bring innovative therapies to patients with early-stage cutaneous T-cell lymphoma (“CTCL”). The company’s lead candidate,…

ThursdayApr 03, 2025 9:00 am

Nightfood Holdings Inc. (NGTF) Revolutionizing Hotel Operations with Skytech AI-Driven Robotics Solutions

Solving the ongoing hospitality labor crisis can create billion-dollar companies Nightfood’s unique RaaS business model lowers barriers to entry while maximizing revenue per client Nightfood’s subsidiaries Skytech and Future Hospitality Ventures (RoboOp365) provide breakthrough RaaS solutions for both front and back of house The hospitality industry is undergoing a radical transformation as automation promises to forever change the hotel labor landscape. With the rapid evolution of AI, robotics has undergone a seismic change. No longer an expensive novelty that delivered little value to hotel operators, robotics is becoming a must-have to remain in business and compete. Combining the most advanced…

WednesdayApr 02, 2025 1:50 pm

Quant Strats 2025 Explores AI, Machine Learning, and the Future of Quant Finance

Quant Strats USA 2025, held on March 11 at Quorum by Convene in New York, brought together over 380 professionals in quantitative finance, with 70% of attendees representing the Buy-Side, including hedge funds, asset managers, and investment banks. The event reaffirmed its role as a premier forum for exploring advancements in artificial intelligence (“AI”), machine learning (“ML”), and large language models (“LLMs”) within finance, offering attendees unparalleled access to industry-leading insights and networking opportunities. The conference featured over 50 expert speakers who examined how AI and ML are no longer just theoretical innovations but essential tools shaping investment strategies, risk…

WednesdayApr 02, 2025 9:45 am

Clene Inc. (NASDAQ: CLNN) to Share CNM-Au8(R) Progress at Jones Las Vegas Conference

The company will present at the Jones Las Vegas Technology and Innovation Conference on April 8-9, to update investors on its lead drug candidate. The conference will provide one-on-one meetings and networking opportunities for institutional investors and executives. Clene recently received FDA guidance on a potential accelerated approval pathway for CNM-Au8 in ALS treatment. New analyses suggest CNM-Au8 improves survival for ALS patients, with a 4.1-month increase in restricted mean survival time. Clene plans to begin enrollment for a Phase 3 confirmatory trial (RESTORE-ALS) in mid-2025. Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage…

WednesdayApr 02, 2025 9:00 am

ZJ Events to Connect the Global Counterculture Community at the Alternative Products Expo, Miami

The ZJ Alternative Products Expo will be held from April 3-5, 2025, at the Mana Wynwood Convention Center in Miami. The expo showcases the latest trends and the finest products and services of the counterculture community, tapping a worldwide audience. With Miami emerging as the epicenter of flavors, cultures, and smoke shops, the event aims to blend the local flavor of Florida with the rest of America. ZJ Events organizes networking events by compiling valuable data on alternative products and presenting to leading brands, manufacturers, and dealers. They provide the counterculture community with a robust platform for exciting learning and…

TuesdayApr 01, 2025 10:30 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Secures $7.3M Deal for Camillus Solar Project

SolarBank announced the sale of a 3.26 MW Camillus Solar Project to Solar Advocate Development LLC. The project will be built on a closed landfill and provide renewable energy to local subscribers. The project was awarded $1.06M in state incentives awarded under the NY-Sun Program. This marks the eighth project SolarBank has developed for Solar Advocate since 2018, and is the latest in a series of recent solar projects and battery storage systems the company has been developing. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and…

TuesdayApr 01, 2025 9:45 am

The MoneyShow Masters Symposium 2025 Offers an Important Opportunity for Investment and Financial Education

The MoneyShow Masters Symposium will be held in Dallas from April 4 to 5, 2025, and it will be an exclusive event that brings together high-net-worth investors and top experts in the field of finance. This two-day symposium will provide a robust platform for investors to learn from world-renowned fundamental and technical analysts, professional traders, and global market strategists. MoneyShow has been working with traders and investors for the last 44 years, guiding and providing them with optimal resources to maximize their profits. MoneyShow hosts networking events where financial wizards help traders and investors to safeguard and strengthen their portfolios.…

TuesdayApr 01, 2025 9:00 am

DGE’s 5th PRC Performance Optimization Summit in Philadelphia to Cover all Aspects of Promotional Review

The 5th PRC Performance Optimization Summit by DGE will be held in Philadelphia on April 29-30, 2025. DGE invites industry professionals to discuss compliance and the expertise needed to get the best regulatory results for advertising/promotional material. The summit is hosted by Dynamic Global Events (“DGE”), a pioneer in organizing B2B events for life science companies. DGE offers the biopharma, healthcare, and medical device industries a robust forum for discussion, education, and collaboration. Promotional review committees must be well-equipped in a rapidly evolving regulatory environment to stay abreast of the best practices for new technologies and platforms. Teams must listen…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: April 2025